FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Fdc Ciprofloxacin ophthalmic solution Recall

Ciprofloxacin ophthalmic solution USP, 0

FDC Limited · Aurangabad, Maharashtra State, N/A

Risk level
Class II
Reported by FDA
Aug 7, 2024
Recall ID
D-0623-2024
Check your lot numberHow we source this data

Summary

Fdc recalled Ciprofloxacin ophthalmic solution starting Jul 23, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0623-2024 on Aug 7, 2024. Reason: Defective container: unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle. Status: Ongoing.

Why it was recalled

Defective container: unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.

Product description

Ciprofloxacin ophthalmic solution USP, 0.3% as base, package in bottles: a) 10 mL (NDC 69315-308-10), b) 2.5 mL (NDC 69315-308-02), Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ. Manufactured by: FDC Limited, Maharashtra, India.

Lot numbers, UPCs & expiration codes

Lot#: a) 084C040, Exp 02/28/2026; b) 084A024, Exp12/31/2025.

Where it was sold

U.S. A. Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0623-2024
Classification
Class II
Status
Ongoing
Recall initiated
Jul 23, 2024
FDA report date
Aug 7, 2024
Quantity
66,528 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
FDC Limited

Original FDA data

Every field from FDA enforcement report D-0623-2024, exactly as published.

Show all FDA fields
City
Aurangabad, Maharashtra State
Status
Ongoing
Country
India
Event ID
95027
Address
B-8 MIDC Industrial Area
Address (line 2)
Waluj District
Code information
Lot#: a) 084C040, Exp 02/28/2026; b) 084A024, Exp12/31/2025.
Report date
Aug 7, 2024
Product type
Drugs
Recall number
D-0623-2024
Classification
Class II
Recalling firm
FDC Limited
Product quantity
66,528 bottles
Reason for recall
Defective container: unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Ciprofloxacin ophthalmic solution USP, 0.3% as base, package in bottles: a) 10 mL (NDC 69315-308-10), b) 2.5 mL (NDC 69315-308-02), Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ. Manufactured by: FDC Limited, Maharashtra, India.
Distribution pattern
U.S. A. Nationwide
Recall initiation date
Jul 23, 2024
Initial firm notification
Letter
Center classification date
Aug 1, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0623-2024, published Aug 7, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls